Takeda Pharmaceutical's diabetes drug Actos outperformed GlaxoSmithKline's Avandia in controlling blood sugar and lipid levels without increasing heart attack risks, researchers report. Actos also proved more effective in lowering LDL cholesterol levels and improving HDL cholesterol levels in an analysis of clinical trial data.

Full Story:

Related Summaries